A new venous needle (VN) that also can be used as an arterial needle (
AN) has been designed to diminish the undesirable hemodynamic effects
of dialysis with high blood flow rate (300-600 ml/min) in arteriovenou
s polytetrafluoroethylene grafts, and in accesses of short length (U.S
. Patent No. 5,662,619). The preferred embodiment has one distal openi
ng, two lateral openings, and two diverters located in the interior su
rface of the shaft adjacent to each lateral opening. The diverters fac
ilitate the flow of blood to the outside of the needle through the lat
eral openings. The new VN ejects three jets of blood, contrary to the
currently used VN, which ejects one jet of high velocity. This decreas
es the velocity of the VN flow and the velocity; turbulence; wall shea
r stress; and positive pressure of the flow, past the VN, during dialy
sis. These may decrease the endothelial damage, intimal hyperplasia, s
tenoses, thromboses, and recirculation of dialysis blood (RODB). When
used as an AN, the new needle lowers the negative pressure surrounding
the AN and the RODB. In summary, the new needle may decrease the comp
lications and prolong the life span of the accesses and improve the pe
rformance of dialysis.